Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > reading material

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Mar 26, 2021 2:24pm

129 Views

Post# 32887515

RE:RE:RE:reading material

The combination of both X-rays and NIR has an even greater anti Tumor effect, but they can opt to only use X-rays and treat multiple times IMO

DJDawg wrote:
Great info. Thanks. So they need to activate by xray followed by NIR laser. Doesn't that mean that it wouldn't be as good as hoped for deep tissue or intracranial malignancy?

<< Previous

Bullboard Posts

Next >>

Barrick Gold employees detained in Mali amid ongoing dispute